Literature DB >> 7927736

Lymphocyte proliferation in response to Brucella abortus 2308 or RB51 antigens in mice infected with strain 2308, RB51, or 19.

M G Stevens1, S C Olsen, G W Pugh.   

Abstract

Lymphocyte proliferation to 22 protein fractions (106 to 18 kDa) of Brucella abortus 2308 or the lipopolysaccharide O-antigen-deficient mutant of 2308, strain RB51, was measured for 20 weeks after infection of mice with strain 2308, RB51, or 19. Throughout the 20-week study, the 22 protein fractions of 2308 and RB51 induced a similar pattern of proliferation when they were incubated with lymphocytes from the infected mice. In addition, during the 20 weeks, lymphocytes from all groups of infected mice exhibited the highest proliferation when the lymphocytes were incubated with 18-kDa or smaller proteins from either 2308 or RB51. Lymphocytes obtained from mice at 6 weeks after infection with strain RB51 or 19 exhibited similar proliferation to the 18-kDa proteins of S2308 or SRB51. Lymphocytes from strain 2308-infected mice did not proliferate to these proteins until 10 weeks after infection, and the responses were similar to those in strain RB51-infected mice but lower than those in strain 19-infected mice. Lymphocytes obtained from mice at 20 weeks after infection with strain 19 or 2308 proliferated to most of the 22 fractions of 2308 or RB51, which contained 106- to 18-kDa proteins. However, lymphocytes obtained from strain RB51-infected mice at 20 weeks did not proliferate to any of these fractions. These results indicate that mice infected with RB51 have less-persistent lymphocyte proliferative responses to 2308 proteins than do mice infected with 2308 or 19. In addition, all 2308 proteins that stimulate lymphocyte proliferation appear to be present in RB51.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927736      PMCID: PMC303161          DOI: 10.1128/iai.62.10.4659-4663.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Virulence associated proteins of Brucella abortus identified by paired two-dimensional gel electrophoretic comparisons of virulent, vaccine and LPS deficient strains.

Authors:  B A Sowa; K A Kelly; T A Ficht; L G Adams
Journal:  Appl Theor Electrophor       Date:  1992

2.  Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.

Authors:  L N Araya; P H Elzer; G E Rowe; F M Enright; A J Winter
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

3.  Comparative histopathology in BALB/c mice infected with virulent and attenuated strains of Brucella abortus.

Authors:  F M Enright; L N Araya; P H Elzer; G E Rowe; A J Winter
Journal:  Vet Immunol Immunopathol       Date:  1990-10       Impact factor: 2.046

4.  Outer membrane proteins from rough strains of four Brucella species.

Authors:  J M Santos; D R Verstreate; V Y Perera; A J Winter
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

5.  Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus.

Authors:  N F Cheville; M G Stevens; A E Jensen; F M Tatum; S M Halling
Journal:  Am J Vet Res       Date:  1993-10       Impact factor: 1.156

6.  Bacterial survival, lymph node changes, and immunologic responses of cattle vaccinated with standard and mutant strains of Brucella abortus.

Authors:  N F Cheville; A E Jensen; S M Halling; F M Tatum; D C Morfitt; S G Hennager; W M Frerichs; G Schurig
Journal:  Am J Vet Res       Date:  1992-10       Impact factor: 1.156

7.  Immunologic, histopathologic, and bacteriologic responses of five strains of mice to Brucella abortus strain 2308.

Authors:  G W Pugh; E S Zehr; V P Meador; M Phillips; T J McDonald; B L Deyoe
Journal:  Am J Vet Res       Date:  1989-03       Impact factor: 1.156

8.  Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen.

Authors:  M Phillips; B L Deyoe; P C Canning
Journal:  Am J Vet Res       Date:  1989-12       Impact factor: 1.156

9.  Monoclonal antibodies to Brucella surface antigens associated with the smooth lipopolysaccharide complex.

Authors:  G G Schurig; C Hammerberg; B R Finkler
Journal:  Am J Vet Res       Date:  1984-05       Impact factor: 1.156

10.  Lymphocyte proliferation in response to immunodominant antigens of Brucella abortus 2308 and RB51 in strain 2308-infected cattle.

Authors:  M G Stevens; S C Olsen; N F Cheville
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

View more
  8 in total

1.  Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies.

Authors:  V Weynants; D Gilson; A Cloeckaert; A Tibor; P A Denoel; F Godfroid; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

2.  Lymphocyte proliferative responses of goats vaccinated with Brucella melitensis 16M or a delta purE201 strain.

Authors:  S C Olsen; N F Cheville; M G Stevens; H H Houng; E S Drazek; T L Hadfield; R L Warren; D L Hoover
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Carlos A Velikovsky; Juliana Cassataro; Guillermo H Giambartolomei; Fernando A Goldbaum; Silvia Estein; Raul A Bowden; Laura Bruno; Carlos A Fossati; Moisés Spitz
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle.

Authors:  P A Denoel; T K Vo; A Tibor; V E Weynants; J M Trunde; G Dubray; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.

Authors:  M G Stevens; S C Olsen; G W Pugh; D Brees
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51.

Authors:  M G Stevens; S C Olsen; G W Pugh
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

Review 7.  What have we learned from brucellosis in the mouse model?

Authors:  María-Jesús Grilló; José María Blasco; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno
Journal:  Vet Res       Date:  2012-04-13       Impact factor: 3.683

8.  Proteomic Analysis of Membrane Blebs of Brucella abortus 2308 and RB51 and Their Evaluation as an Acellular Vaccine.

Authors:  Minerva Araiza-Villanueva; Eric Daniel Avila-Calderón; Leopoldo Flores-Romo; Juana Calderón-Amador; Nammalwar Sriranganathan; Hamzeh Al Qublan; Sharon Witonsky; Ma Guadalupe Aguilera-Arreola; María Del Socorro Ruiz-Palma; Enrico A Ruiz; Francisco Suárez-Güemes; Zulema Gómez-Lunar; Araceli Contreras-Rodríguez
Journal:  Front Microbiol       Date:  2019-11-29       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.